Knut

Knut is a Paris-based biotechnology company specializing in generative artificial intelligence for protein design. The company develops advanced computational models to engineer novel proteins with optimized properties for therapeutic and industrial use. By combining deep learning with structural biology, Knut's platform aims to significantly reduce the time and cost associated with protein engineering. Their technology focuses on improving protein stability, binding affinity, and overall developability. Knut is positioned at the intersection of AI and biologics discovery, targeting the next generation of protein-based medicines.